Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors

NCT01196936 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Tamoxifen Citrate
DRUG: Placebo
PROCEDURE: Digital mammography
OTHER: immunohistochemistry staining method
OTHER: pharmacological study
OTHER: laboratory biomarker analysis
GENETIC: protein expression analysis
OTHER: pharmacogenomic studies
OTHER: questionnaire administration
PROCEDURE: Fine needle aspiration
OTHER: Quality of Life Assessment

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]